Table 2 Factors associated with long-term stented-territory infarction in VBS
Variable (N = 87) | cHR (95% CI) | P-value | aHR (95% CI) | P-value |
|---|---|---|---|---|
Age | 1.02 (0.97–1.07) | 0.544 | ||
Male sex | 1.50 (0.34–6.70) | 0.597 | ||
Hypertension | 1.40 (0.39–5.02) | 0.606 | ||
Diabetes | 3.17 (1.09–9.18) | 0.034 | 3.82 (1.24–11.7) | 0.019 |
Hyperlipidemia | 0.40 (0.13–1.28) | 0.122 | ||
Coronary artery disease | 1.91 (0.60–6.09) | 0.276 | ||
Stroke history | 1.51 (0.53–4.32) | 0.438 | ||
HbA1c, % | 1.48 (0.96–2.28) | 0.075 | ||
LDL, mg/dL | 1.00 (0.99–1.01) | 0.743 | ||
ARU ≥550 | 1.33 (0.40–4.43) | 0.640 | ||
PRU ≥275 | 2.03 (0.45–9.15) | 0.359 | ||
% PI < 20% | 2.23 (0.72–6.90) | 0.166 | ||
Intracranial lesion | 1.47 (0.49–4.39) | 0.491 | ||
Symptomatic stenosis | 1.28 (0.17–9.81) | 0.810 | ||
Number of stents ≥2 | 11.6 (1.42–94.0) | 0.022 | 22.4 (2.4–206.4) | 0.006 |
Maximum diameter of stents, mm | 0.88 (0.64–1.22) | 0.445 | ||
Total length of stents, mm | 1.01 (0.96–1.07) | 0.676 | ||
Pre-ballooning dilatation | 2.36 (0.31–18.0) | 0.409 | ||
Post-ballooning dilatation | 0.78 (0.22–2.82) | 0.708 | ||
Maximum balloon pressure, atm | 0.94 (0.81–1.09) | 0.388 | ||
In-stent restenosis | 2.37 (0.65–8.64) | 0.193 |